NEU 6.41% $15.27 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-93

  1. 520 Posts.
    lightbulb Created with Sketch. 1265
    finally the Anavex data falsifiers come out and throw in the towel on Rett.for Neuren and Acadia, at least 7 years of absolute world exclusivity are guaranteed, which already translates into several hundreds of millions of dollars, which will enter our coffers in the medium to long term. the driving force in the coming months will be the adhesion to Daybue of all that part of the Rett community that was involved or expected to be involved in the Anavex studies.the institutional investiture of large international entities, particularly Chinese ones, is increasingly realistic and impressive by virtue of the documentation I recently posted, relaunched not by chance, by our deputy director Gerry Zhau.

    Good luck
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.